🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluated the safety and efficacy of 26 weeks treatment with ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-11
Trial ID
NCT00567996
Treatments Being Tested
This is an exempt, retrospective study of a limited set of information obta...
Status
Unknown
Location
Ed Pigott
Start Date
2015-09
Trial ID
NCT02544581
Treatments Being Tested
Propeller Health is collaborating with the City of Louisville and other loc...
Status
Completed
Location
Jefferson County
Start Date
2012-06
Trial ID
NCT02162576
Treatments Being Tested
This will be a non-drug interventional cross-sectional study, where the scr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12
Trial ID
NCT02293265
Treatments Being Tested
Chronic obstructive pulmonary disease is heterogeneous lung condition chara...
Status
Unknown
Location
Nermen Mohammed Abuelkassem
Start Date
2023-02-20
Trial ID
NCT05748977
Treatments Being Tested
This study evaluated the 1 year safety, tolerability and efficacy of indaca...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-05
Trial ID
NCT00677807
Treatments Being Tested
Since 2006 there was a plateau in world wide mortality from asthma. Overrel...
Status
Completed
Location
Pulmonary Section
Start Date
2017-03-10
Trial ID
NCT03498742
Treatments Being Tested
This is a first in human study of ETD002 a new drug being developed for the...
Status
Completed
Location
Hammersmith Medicines Research
Start Date
2020-08-13
Trial ID
NCT04488705
Severe refractory asthma affects about 3.5% of asthma patients, often neces...
Status
Unknown
Location
Isala
Start Date
2024-05-01
Trial ID
NCT06360393
Treatments Being Tested
The purpose of this study is to characterize and compare the molecular gene...
Status
Unknown
Location
University of Calgary
Start Date
2022-04-21
Trial ID
NCT05078021
Treatments Being Tested